News

Vaxcyte's VAX-31 Vaccine Shows Promising Phase 1/2 Study Results

Vaxcyte's VAX-31 Vaccine Shows Promising Phase 1/2 Study Results

Positive Phase 1/2 Study Results for Vaxcyte's VAX-31 Vaccine

Vaxcyte, Inc. (Nasdaq: PCVX), a company focused on vaccine innovation and currently in the clinical stage, has recently shared encouraging topline results from its Phase 1/2 study of VAX-31. This innovative 31-valent pneumococcal conjugate vaccine (PCV) was evaluated for its safety, tolerability, and immunogenicity in a study involving 1,015 healthy adults aged 50 and older, a group that is particularly vulnerable to invasive pneumococcal disease (IPD).

Strong Immune Responses Observed

The findings revealed that VAX-31 successfully triggered strong opsonophagocytic activity (OPA) immune responses across all 31 serotypes examined. Impressively, both the middle and high doses of the vaccine met or surpassed the regulatory immunogenicity benchmarks for every serotype. This is a significant milestone, as pneumococcal diseases are a major health threat for older adults, leading to a high number of hospitalizations.

Safety Profile Comparable to Prevnar 20

During the six-month evaluation period, VAX-31 demonstrated good tolerability, with a safety profile akin to that of Prevnar 20, another prominent pneumococcal vaccine. The local and systemic reactions reported were mostly mild to moderate and typically resolved within a few days. Notably, there were no serious adverse events linked to VAX-31.

Future Perspectives for VAX-31 Development

Encouraged by these strong results, Vaxcyte is eager to move VAX-31 into Phase 3 of its clinical program. The company plans to kick off pivotal non-inferiority studies by mid-2025, aiming to share topline safety and immunogenicity results in 2026.

Advancements in Pneumococcal Vaccine Development

The promising results of VAX-31 highlight Vaxcyte’s dedication to creating innovative solutions for preventing IPD. CEO Grant Pickering underscored the importance of these findings, which strengthen their carrier-sparing platform. This platform is designed to develop vaccines that can address a wider range of circulating strains and historically significant serotypes, which are crucial in fighting infections that lead to high rates of morbidity and mortality.

Key Serotypes Targeted by VAX-31

VAX-31 is designed to provide coverage for over 95% of the IPD serotypes circulating among older adults in the United States. This includes serotypes responsible for serious health issues like meningitis and sepsis, which are frequently associated with antibiotic resistance. By offering extensive protection, VAX-31 has the potential to make a significant positive impact on public health, especially for at-risk populations.

Acknowledgment of Study Participants and Team

The team at Vaxcyte expressed heartfelt appreciation to all study participants and investigators who took part in the Phase 1/2 study. Their invaluable contributions play a crucial role in advancing vaccine research aimed at combating bacterial diseases.

Frequently Asked Questions

What is VAX-31?

VAX-31 is a 31-valent pneumococcal conjugate vaccine candidate developed by Vaxcyte, designed to prevent invasive pneumococcal disease among adults and infants.

What were the study results for VAX-31?

The Phase 1/2 study results showed strong safety and tolerability, with robust immune responses against all serotypes tested.

When will subsequent studies for VAX-31 begin?

Vaxcyte plans to initiate Phase 3 pivotal studies for VAX-31 by mid-2025, with results expected in 2026.

How does VAX-31 compare to other pneumococcal vaccines?

VAX-31 has shown a safety profile comparable to Prevnar 20 and aims to deliver broader protection against more serotypes responsible for IPD.

What impact could VAX-31 have on public health?

If successful, VAX-31 could significantly reduce the incidence of IPD in older adults, addressing a critical public health concern linked to high hospitalization rates and antibiotic resistance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Navan’s Travel Survey Sells Friction as a Business Case

Updated Category News Views 154

A forgotten charger can turn a routine trip into a small mutiny. That is the useful little truth sitting underneath Navan’s new survey of 2,000 Americans who travel for leisure or business. The company is poking at the annoyances people carry from the bedroom packing pile to the jet bridge: forgotten items, rushed airport arrivals, pre-flight drinks, chatty strangers,...

Continue Reading
SecureSpace Plants a Fifth Flag in Miami Beach Storage

Updated Category News Views 111

A small box on Alton Road may carry outsized weight Miami Beach does not hand out cheap, easy real estate wins, which is why SecureSpace's opening at 633 Alton Road deserves a closer look than its modest footprint might suggest. The newly rebranded SecureSpace Miami Beach facility has 18,358 square feet of traditional storage and locker space spread across 536 units, plus...

Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools

Updated Category News Views 187

Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 196

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 123

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
AMPERA Joins Berto to Power Future Energy Innovations

Updated Category News Views 172

The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....

Continue Reading
Kobo and CloudLibrary Make Library Ebooks Much Easier

Updated Category News Views 107

A tiny button can change whether a digital service gets used Borrowing an ebook ought not feel like assembling a radio in a dark garage, yet that is roughly where library reading has landed for plenty of people. OCLC's new CloudLibrary integration with Kobo strips out a particularly annoying step: U.S. and Canadian users can link accounts once, borrow a title, and have it...

Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial

Updated Category News Views 68

Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...

Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays

Updated Category News Views 65

A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...

Continue Reading
VisionX AI Bets on Graphs to Track Crypto Crime Nets

Updated Category News Views 74

Money laundering rarely travels in a straight line, and that is precisely the sore spot VisionX AI is trying to jab. The Singapore-based RegTech company has introduced AEGIS, a proprietary Large Graph Model built around financial-crime networks, alongside TraceX, a blockchain investigation platform meant to turn that network view into usable leads. It is a sensible...

Continue Reading

Top 5 Most Recently Viewed Articles

Rocket Lab USA's Earnings Predictions and Market Insights

Updated Category News Views 157

Earned Expectations from Rocket Lab USA Rocket Lab USA (NASDAQ: RKLB) is gearing up for its quarterly earnings report, anticipated by investors with curiosity and optimism. The forthcoming announcement promises to deliver crucial insights into the company's financial health and growth trajectory. Expected Earnings Snapshot Analysts forecast that Rocket Lab will register...

Continue Reading
Upcoming Q2 Financial Results Announcement from Parkland

Updated Category News Views 108

Exciting News from Parkland Corporation Parkland Corporation, known for its dedication to providing quality fuel and convenience products, is gearing up for its next financial milestone. The company anticipates unveiling its second quarter results for 2025, a pivotal moment for investors and stakeholders alike. Key Announcement Details Scheduled to be disclosed after the...

Continue Reading
FLSmidth Secures Major Flotation Technology Contract for Iron Ore

Updated Category News Views 201

FLSmidth Secures Major Flotation Technology Contract for Iron Ore A leading Indian miner and steel producer has made a significant decision by selecting FLSmidth & Co. A/S to deliver a comprehensive flotation technology package for their state-of-the-art iron ore beneficiation plant. This facility is poised to be among the largest and most efficient of its kind globally,...

Continue Reading
Arthur J. Gallagher & Co. Plans Financial Results Conference

Updated Category News Views 118

Arthur J. Gallagher & Co. Announces Key Earnings Details Arthur J. Gallagher & Co. (NYSE: AJG) is gearing up to share its financial results for the fourth quarter of 2025. The announcement will be made after market closure on Thursday, January 29, 2026. Following this release, interested investors will find a printer-friendly version on the company’s official website,...

Continue Reading
Exelixis Faces Investor Scrutiny Amid Financial Reporting Concerns

Updated Category News Views 234

Exelixis under Investigation by Pomerantz Law Firm Pomerantz LLP, a renowned law firm, has initiated an investigation concerning investors of Exelixis, Inc. (NASDAQ: EXEL). This inquiry focuses on potential securities fraud or other unlawful practices involving the company and its leadership. Insights into Recent Financial Performance Recently, Exelixis reported its...

Continue Reading